June 1, 2017 Sophia Vida
Biotech & Pharma

Americans May Have Been Overcharged $1 Billion For EpiPen Devices

According to a U.S. senator who made the remark on Wednesday, American taxpayers may have steeply overpaid for EpiPens over the last ten years. How much is steep? $1.27 billion over what should have been the charges. “The fact that the EpiPen overpayment is so much more than anyone discussed publicly should worry every taxpayer,” … Continue reading “Americans May Have Been Overcharged $1 Billion For EpiPen Devices”